AMZN
Amazon.com, Inc.
AMZN has the edge over BRLT overall, supported by stronger valuation and lower modeled downside.
BRLT
Brilliant Earth Group, Inc.
BRLT's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BRLT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
BRLT's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
BRLT PE Valuation
BRLT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 16x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BRLT on the outlook, with more favorable revenue expectations.
BRLT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BRLT to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BRLT on earnings quality, reporting a profit while its opponent remains loss making.
BRLT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.08 | — |
| Q3 2026 | -$0.27 | -$0.24 |
| Q2 2026 | -$0.30 | -$0.27 |
| Q1 2026 | -$0.32 | -$0.31 |
| Q4 2025 | -$0.25 | -933% |
| Q3 2025 | -$0.03 | -250% |
| Q2 2025 | -$0.03 | -160% |
| Q1 2025 | -$0.01 | -120% |
BRLT lost $0.27 per share over the past year, a bigger loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BRLT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BRLT on profitability, with a higher operating margin.
BRLT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.8M | +2.3% |
| Q2 2026 | $115.1M | +5.7% |
| Q1 2026 | $99.5M | +6% |
| Q4 2025 | $124.4M | +4.1% |
| Q3 2025 | $110.3M | +10% |
| Q2 2025 | $108.9M | +3.3% |
| Q1 2025 | $93.9M | -3.5% |
| Q4 2024 | $119.5M | -3.9% |
BRLT's revenue has grown year over year for six quarters in a row: $113M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.7% | +2.3 points |
| Q2 2026 | 0.4% | +1.5 points |
| Q1 2026 | -8.9% | -5.2 points |
| Q4 2025 | 0% | -2 points |
| Q3 2025 | -0.6% | +0.5 points |
| Q2 2025 | -1.1% | -2.2 points |
| Q1 2025 | -3.8% | -4.7 points |
| Q4 2024 | 2% | +1.1 points |
BRLT's operating margin was 1.7% last quarter, up 2.3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BRLT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | +$3.9M |
| Q2 2026 | $16.5M | +109% |
| Q1 2026 | -$19.3M | -$11.5M |
| Q4 2025 | $5.7M | -52% |
| Q3 2025 | -$3K | -100% |
| Q2 2025 | $7.9M | +23% |
| Q1 2025 | -$7.9M | -$1.5M |
| Q4 2024 | $11.9M | +26% |
BRLT has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over BRLT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BRLT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +414K shares |
| 1 year | +581% | +87.1M shares |
| 3 years | +5.4% | +5.2M shares |
| 5 years | +6.6% | +6.3M shares |
BRLT has 102M diluted shares, up 581% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $96,000 |
| Q2 2025 | $197,000 |
| Q1 2025 | $163,000 |
| Q4 2024 | $200,000 |
BRLT hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BRLT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -107.9x | Net Cash |
| Q3 2025 | -23.7x | Net Cash |
| Q2 2025 | -40.6x | Net Cash |
| Q1 2025 | -20.4x | Net Cash |
| Q4 2024 | -12.3x | Net Cash |
| Q3 2024 | -13.2x | Net Cash |
| Q2 2024 | -9.4x | Net Cash |
| Q1 2024 | -9.0x | Net Cash |
BRLT has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BRLT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 61.6 | Neutral |
BRLT's weekly RSI is 44 (neutral) and its Stochastic is 62 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BRLT PE vs Consumer Cyclical Sector
| Metric | BRLT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
BRLT has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BRLT on trend strength, trading above more of its moving averages.
BRLT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.45 | 12% below |
| 20 week MA | $1.34 | 5.2% below |
| 50 week MA | $1.41 | 9.9% below |
| 100 week MA | $1.61 | 21% below |
| 200 week MA | $2.33 | 45% below |
BRLT is in a downtrend: it's below all five of its weekly moving averages, and 45% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BRLT on returns for 2026, with the stronger performance.
BRLT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.2 | $16.1 | +5.5% |
| 2022 | $16.1 | $4.09 | -75% |
| 2023 | $4.09 | $3.72 | -9% |
| 2024 | $3.72 | $2.04 | -45% |
| 2025 | $2.04 | $1.78 | -13% |
| 2026 YTD | $1.78 | $1.27 | -29% |
BRLT has finished four years in a row lower, and it's down 29% so far in 2026.